##gff-version 3
##sequence-region O43196 1 834
O43196	UniProtKB	Chain	1	834	.	.	.	ID=PRO_0000115202;Note=MutS protein homolog 5	
O43196	UniProtKB	Nucleotide binding	592	599	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255	
O43196	UniProtKB	Alternative sequence	179	179	.	.	.	ID=VSP_017113;Note=In isoform 3 and isoform 4. T->TPPGDLRFTPIPLLIPSQ;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
O43196	UniProtKB	Alternative sequence	654	654	.	.	.	ID=VSP_017114;Note=In isoform 2 and isoform 4. Q->QQ;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|Ref.4;Dbxref=PMID:15489334	
O43196	UniProtKB	Alternative sequence	745	774	.	.	.	ID=VSP_017115;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
O43196	UniProtKB	Natural variant	29	29	.	.	.	ID=VAR_025082;Note=P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.5;Dbxref=dbSNP:rs2075789	
O43196	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_025083;Note=L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.5;Dbxref=dbSNP:rs28381349	
O43196	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_025084;Note=Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.5;Dbxref=dbSNP:rs28381358	
O43196	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_025085;Note=V->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.5;Dbxref=dbSNP:rs28381359	
O43196	UniProtKB	Natural variant	351	351	.	.	.	ID=VAR_025086;Note=R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.5;Dbxref=dbSNP:rs28399976	
O43196	UniProtKB	Natural variant	353	353	.	.	.	ID=VAR_078116;Note=In POF13%3B unknown pathological significance. L->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28175301;Dbxref=PMID:28175301	
O43196	UniProtKB	Natural variant	377	377	.	.	.	ID=VAR_025087;Note=L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.5;Dbxref=dbSNP:rs28399977	
O43196	UniProtKB	Natural variant	487	487	.	.	.	ID=VAR_078117;Note=In POF13%3B decreased function in DNA repair as suggested by the persistence of gamma-H2AX foci following cell treatment with etoposide. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28175301;Dbxref=dbSNP:rs1060505055,PMID:28175301	
O43196	UniProtKB	Natural variant	703	703	.	.	.	ID=VAR_078118;Note=In POF13%3B unknown pathological significance. I->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28175301;Dbxref=dbSNP:rs752657544,PMID:28175301	
O43196	UniProtKB	Natural variant	786	786	.	.	.	ID=VAR_025088;Note=P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.5;Dbxref=dbSNP:rs1802127	
O43196	UniProtKB	Sequence conflict	764	764	.	.	.	Note=P->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
